Cartesian Therapeutics, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
Cartesian Therapeutics, Inc. (RNAC) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of 0.10% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2026-03-09
- Cartesian Therapeutics, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2025 was 0.10%, a 90.00% decline from fiscal 2024.
- Cartesian Therapeutics, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2024 was 1.00%.
- Cartesian Therapeutics, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2023 was -1.60%.
- Cartesian Therapeutics, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2022 was -18.60%, a 324.10% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month |
|---|---|
| 2025-12-31 | 0.10% 10-K · filed 2026-03-09 |
| 2024-12-31 | 1.00% 10-K · filed 2025-03-13 |
| 2023-12-31 | -1.60% 10-K · filed 2025-03-13 |
| 2022-12-31 | -18.60% 10-K · filed 2024-03-07 |
| 2021-12-31 | 8.30% 10-K · filed 2024-03-07 |
| 2020-12-31 | -2.90% 10-K · filed 2023-03-02 |
| 2019-12-31 | -2.10% 10-K · filed 2022-03-10 |
| 2018-12-31 | -0.50% 10-K · filed 2021-03-12 |
| 2017-12-31 | -0.10% 10-K · filed 2020-03-12 |
| 2016-12-31 | -1.10% 10-K · filed 2019-03-15 |
| 2015-12-31 | -0.70% 10-K · filed 2018-03-15 |
| 2014-12-31 | -0.70% 10-K · filed 2017-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |